Cargando…

Source localized infraslow neurofeedback training in people with chronic painful knee osteoarthritis: A randomized, double-blind, sham-controlled feasibility clinical trial

Persistent pain is a key symptom in people living with knee osteoarthritis (KOA). Infra-slow Neurofeedback (ISF-NF) training is a recent development focusing on modulating cortical slow-wave activity to improve pain outcomes. A parallel, two-armed double-blinded, randomized sham-controlled, feasibil...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathew, Jerin, Adhia, Divya Bharatkumar, Smith, Mark Llewellyn, De Ridder, Dirk, Mani, Ramakrishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366917/
https://www.ncbi.nlm.nih.gov/pubmed/35968375
http://dx.doi.org/10.3389/fnins.2022.899772
_version_ 1784765674098262016
author Mathew, Jerin
Adhia, Divya Bharatkumar
Smith, Mark Llewellyn
De Ridder, Dirk
Mani, Ramakrishnan
author_facet Mathew, Jerin
Adhia, Divya Bharatkumar
Smith, Mark Llewellyn
De Ridder, Dirk
Mani, Ramakrishnan
author_sort Mathew, Jerin
collection PubMed
description Persistent pain is a key symptom in people living with knee osteoarthritis (KOA). Infra-slow Neurofeedback (ISF-NF) training is a recent development focusing on modulating cortical slow-wave activity to improve pain outcomes. A parallel, two-armed double-blinded, randomized sham-controlled, feasibility clinical trial aimed to determine the feasibility and safety of a novel electroencephalography-based infraslow fluctuation neurofeedback (EEG ISF-NF) training in people with KOA and determine the variability of clinical outcomes and EEG changes following NF training. Eligible participants attended nine 30-min ISF-NF training sessions involving three cortical regions linked to pain. Feasibility measures were monitored during the trial period. Pain and functional outcomes were measured at baseline, post-intervention, and follow-up after 2 weeks. Resting-state EEG was recorded at baseline and immediate post-intervention. Participants were middle-aged (61.7 ± 7.6 years), New Zealand European (90.5%), and mostly females (62%) with an average knee pain duration of 4 ± 3.4 years. The study achieved a retention rate of 91%, with 20/22 participants completing all the sessions. Participants rated high levels of acceptance and “moderate to high levels of perceived effectiveness of the training.” No serious adverse events were reported during the trial. Mean difference (95% CI) for clinical pain and function measures are as follows for pain severity [active: 0.89 ± 1.7 (−0.27 to 2.0); sham: 0.98 ± 1.1 (0.22–1.7)], pain interference [active: 0.75 ± 2.3 (−0.82 to 2.3); Sham: 0.89 ± 2.1 (−0.60 to 2.4)], pain unpleasantness [active: 2.6 ± 3.7 (0.17–5.1); sham: 2.8 ± 3 (0.62–5.0)] and physical function [active: 6.2 ± 13 (−2.6 to 15); sham: 1.6 ± 12 (−6.8 to 10)]. EEG sources demonstrated frequency-specific neuronal activity, functional connectivity, and ISF ratio changes following NF training. The findings of the study indicated that the ISF-NF training is a feasible, safe, and acceptable intervention for pain management in people with KOA, with high levels of perceived effectiveness. The study also reports the variability in clinical, brain activity, and connectivity changes following training.
format Online
Article
Text
id pubmed-9366917
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93669172022-08-12 Source localized infraslow neurofeedback training in people with chronic painful knee osteoarthritis: A randomized, double-blind, sham-controlled feasibility clinical trial Mathew, Jerin Adhia, Divya Bharatkumar Smith, Mark Llewellyn De Ridder, Dirk Mani, Ramakrishnan Front Neurosci Neuroscience Persistent pain is a key symptom in people living with knee osteoarthritis (KOA). Infra-slow Neurofeedback (ISF-NF) training is a recent development focusing on modulating cortical slow-wave activity to improve pain outcomes. A parallel, two-armed double-blinded, randomized sham-controlled, feasibility clinical trial aimed to determine the feasibility and safety of a novel electroencephalography-based infraslow fluctuation neurofeedback (EEG ISF-NF) training in people with KOA and determine the variability of clinical outcomes and EEG changes following NF training. Eligible participants attended nine 30-min ISF-NF training sessions involving three cortical regions linked to pain. Feasibility measures were monitored during the trial period. Pain and functional outcomes were measured at baseline, post-intervention, and follow-up after 2 weeks. Resting-state EEG was recorded at baseline and immediate post-intervention. Participants were middle-aged (61.7 ± 7.6 years), New Zealand European (90.5%), and mostly females (62%) with an average knee pain duration of 4 ± 3.4 years. The study achieved a retention rate of 91%, with 20/22 participants completing all the sessions. Participants rated high levels of acceptance and “moderate to high levels of perceived effectiveness of the training.” No serious adverse events were reported during the trial. Mean difference (95% CI) for clinical pain and function measures are as follows for pain severity [active: 0.89 ± 1.7 (−0.27 to 2.0); sham: 0.98 ± 1.1 (0.22–1.7)], pain interference [active: 0.75 ± 2.3 (−0.82 to 2.3); Sham: 0.89 ± 2.1 (−0.60 to 2.4)], pain unpleasantness [active: 2.6 ± 3.7 (0.17–5.1); sham: 2.8 ± 3 (0.62–5.0)] and physical function [active: 6.2 ± 13 (−2.6 to 15); sham: 1.6 ± 12 (−6.8 to 10)]. EEG sources demonstrated frequency-specific neuronal activity, functional connectivity, and ISF ratio changes following NF training. The findings of the study indicated that the ISF-NF training is a feasible, safe, and acceptable intervention for pain management in people with KOA, with high levels of perceived effectiveness. The study also reports the variability in clinical, brain activity, and connectivity changes following training. Frontiers Media S.A. 2022-07-28 /pmc/articles/PMC9366917/ /pubmed/35968375 http://dx.doi.org/10.3389/fnins.2022.899772 Text en Copyright © 2022 Mathew, Adhia, Smith, De Ridder and Mani. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Mathew, Jerin
Adhia, Divya Bharatkumar
Smith, Mark Llewellyn
De Ridder, Dirk
Mani, Ramakrishnan
Source localized infraslow neurofeedback training in people with chronic painful knee osteoarthritis: A randomized, double-blind, sham-controlled feasibility clinical trial
title Source localized infraslow neurofeedback training in people with chronic painful knee osteoarthritis: A randomized, double-blind, sham-controlled feasibility clinical trial
title_full Source localized infraslow neurofeedback training in people with chronic painful knee osteoarthritis: A randomized, double-blind, sham-controlled feasibility clinical trial
title_fullStr Source localized infraslow neurofeedback training in people with chronic painful knee osteoarthritis: A randomized, double-blind, sham-controlled feasibility clinical trial
title_full_unstemmed Source localized infraslow neurofeedback training in people with chronic painful knee osteoarthritis: A randomized, double-blind, sham-controlled feasibility clinical trial
title_short Source localized infraslow neurofeedback training in people with chronic painful knee osteoarthritis: A randomized, double-blind, sham-controlled feasibility clinical trial
title_sort source localized infraslow neurofeedback training in people with chronic painful knee osteoarthritis: a randomized, double-blind, sham-controlled feasibility clinical trial
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366917/
https://www.ncbi.nlm.nih.gov/pubmed/35968375
http://dx.doi.org/10.3389/fnins.2022.899772
work_keys_str_mv AT mathewjerin sourcelocalizedinfraslowneurofeedbacktraininginpeoplewithchronicpainfulkneeosteoarthritisarandomizeddoubleblindshamcontrolledfeasibilityclinicaltrial
AT adhiadivyabharatkumar sourcelocalizedinfraslowneurofeedbacktraininginpeoplewithchronicpainfulkneeosteoarthritisarandomizeddoubleblindshamcontrolledfeasibilityclinicaltrial
AT smithmarkllewellyn sourcelocalizedinfraslowneurofeedbacktraininginpeoplewithchronicpainfulkneeosteoarthritisarandomizeddoubleblindshamcontrolledfeasibilityclinicaltrial
AT deridderdirk sourcelocalizedinfraslowneurofeedbacktraininginpeoplewithchronicpainfulkneeosteoarthritisarandomizeddoubleblindshamcontrolledfeasibilityclinicaltrial
AT maniramakrishnan sourcelocalizedinfraslowneurofeedbacktraininginpeoplewithchronicpainfulkneeosteoarthritisarandomizeddoubleblindshamcontrolledfeasibilityclinicaltrial